Global Neglected Tropical Diseases Diagnosis Market Research Report 2021 - ResearchAndMarkets.com

The "Neglected Tropical Diseases Diagnosis - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Information
Content
Key Points: 
  • The "Neglected Tropical Diseases Diagnosis - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at a CAGR of 4% over the period 2020-2027.
  • Conventional, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$4.4 Billion by the end of the analysis period.
  • The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 6.4% CAGR
    The Neglected Tropical Diseases Diagnosis market in the U.S. is estimated at US$1.6 Billion in the year 2020.


The "Neglected Tropical Diseases Diagnosis - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Neglected Tropical Diseases Diagnosis Market to Reach $7.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at a CAGR of 4% over the period 2020-2027.

Conventional, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$4.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Molecular / Modern segment is readjusted to a revised 4.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 6.4% CAGR

The Neglected Tropical Diseases Diagnosis market in the U.S. is estimated at US$1.6 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 33 Featured):

  • Abbott Laboratories
  • Beckman Coulter/Danaher
  • Bio-Rad Laboratories, Inc.
  • Coris Bioconcept SPRL
  • DiaSys Diagnostic Systems GmbH
  • F. Hoffmann-La Roche Ltd.
  • Genome Diagnostics Pvt. Ltd
  • InBios International, Inc.
  • Life Technology
  • Novartis Diagnostics., Ltd.
  • Omega Diagnostics Group PLC
  • Ortho-Clinical Diagnostics
  • Oscar Medicare Pvt Ltd.
  • Premier Medical Corporation Ltd.
  • Siemens Healthcare
  • Thermo Fisher Scientific, Inc.
  • Wako Chemicals, Inc.
  • ZeptoMetrix

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • AUSTRALIA
  • INDIA
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA

IV. COMPETITION

  • Total Companies Profiled: 33

For more information about this report visit https://www.researchandmarkets.com/r/ngfadu